After completing this activity, the reader should be better able to:
• Describe the types of cost analyses used in making decisions about reimbursement for cancer drugs.
• Explain the role of cost-effectiveness in reimbursement decisions in the United States compared with the United Kingdom and Canada.
• Provide an example of how cost-effectivenss analysis may affect decisions about coverage of a new cancer therapy.
To receive continuing education credit, learners must:
• Read the article in its entirety
• Take the CE self-assessment test and complete the evaluation
Please note: The learner must answer at least 70% of the questions on the post-test correctly.
The estimated time to complete this activity is 1 hour.
Your continuing education certificate can be printed by following the directions online after successful completion of the post-test and evaluation.
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE provider number is 447-000-09-008-H04-P. To receive the 1 contact hour of continuing education credit, pharmacists should complete the activity requirements and evaluation at the conclusion of the activity. Approval is valid from the initial release date of April 15, 2009. The expiration date is April 14, 2010. A statement of credit will be available for printing online upon completion of the post-test with a score of 70% or better and the evaluation instrument.
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center (UNMC), Center for Continiung Education.
While the University of Nebraska Medical Center, Center for Continuing Education is an ACPE accredited organization, this does not imply endorsement by the UNMC or ACPE of any commercial products affiliated with this activity.